HK1058479A1 - Sustained-release preparations of quinolone antibiotics and method for preparation thereof - Google Patents

Sustained-release preparations of quinolone antibiotics and method for preparation thereof

Info

Publication number
HK1058479A1
HK1058479A1 HK04101286A HK04101286A HK1058479A1 HK 1058479 A1 HK1058479 A1 HK 1058479A1 HK 04101286 A HK04101286 A HK 04101286A HK 04101286 A HK04101286 A HK 04101286A HK 1058479 A1 HK1058479 A1 HK 1058479A1
Authority
HK
Hong Kong
Prior art keywords
preparation
sustained
release preparations
quinolone antibiotics
quinolone
Prior art date
Application number
HK04101286A
Other languages
English (en)
Inventor
Venkata-Rangarao Kanikanti
Roland Rupp
Wolfgang Weber
Peter Deuringer
Jan-Olav Henck
Heino Stass
Takaaki Nishioka
Yoshifumi Katakawa
Chika Taniguchi
Hitoshi Ichihashi
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of HK1058479A1 publication Critical patent/HK1058479A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK04101286A 2000-06-26 2004-02-23 Sustained-release preparations of quinolone antibiotics and method for preparation thereof HK1058479A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10031043A DE10031043A1 (de) 2000-06-26 2000-06-26 Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
PCT/EP2001/006695 WO2002000219A1 (de) 2000-06-26 2001-06-13 Retard-zubereitungen von chinolon-antibiotika und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
HK1058479A1 true HK1058479A1 (en) 2004-05-21

Family

ID=7646816

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04101286A HK1058479A1 (en) 2000-06-26 2004-02-23 Sustained-release preparations of quinolone antibiotics and method for preparation thereof

Country Status (41)

Country Link
US (3) US7709022B2 (zh)
EP (1) EP1296685B1 (zh)
JP (1) JP4958373B2 (zh)
KR (1) KR100939617B1 (zh)
CN (1) CN1273138C (zh)
AR (1) AR029688A1 (zh)
AT (1) ATE355062T1 (zh)
AU (1) AU2001270573A1 (zh)
BG (1) BG65914B1 (zh)
BR (1) BRPI0111911B8 (zh)
CA (1) CA2414271C (zh)
CU (1) CU23264B7 (zh)
CY (1) CY1107574T1 (zh)
CZ (1) CZ301812B6 (zh)
DE (2) DE10031043A1 (zh)
DK (1) DK1296685T3 (zh)
DO (1) DOP2001000199A (zh)
EE (1) EE04992B1 (zh)
ES (1) ES2282270T3 (zh)
GT (1) GT200100126A (zh)
HK (1) HK1058479A1 (zh)
HN (1) HN2001000132A (zh)
HR (1) HRP20030050B1 (zh)
HU (1) HU229806B1 (zh)
IL (2) IL153333A0 (zh)
MA (1) MA25761A1 (zh)
MX (1) MXPA02012727A (zh)
MY (1) MY140994A (zh)
NO (1) NO325415B1 (zh)
NZ (1) NZ523352A (zh)
PE (1) PE20020207A1 (zh)
PL (1) PL203710B1 (zh)
PT (1) PT1296685E (zh)
RU (1) RU2332204C2 (zh)
SI (1) SI1296685T1 (zh)
SK (1) SK287384B6 (zh)
SV (1) SV2002000505A (zh)
TW (1) TWI279232B (zh)
UA (1) UA83616C2 (zh)
WO (1) WO2002000219A1 (zh)
ZA (1) ZA200210350B (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
KR100564229B1 (ko) * 2002-06-25 2006-03-28 (주)마이크로 사이언스 테크 항균성 또는 항응혈성 의료용품 및 이의 제조방법
KR101173696B1 (ko) * 2003-02-10 2012-08-13 바이엘 파마 악티엔게젤샤프트 플루오로퀴놀론의 국소 적용에 의한 호흡 기관의 세균성질환의 치료
WO2004073729A1 (ja) * 2003-02-21 2004-09-02 Translational Research Ltd. 薬物の経鼻投与用組成物
EP1607117A4 (en) 2003-03-27 2007-10-24 Bioactis Ltd APPLICATOR FOR POWDER MEDICATION IN THE NOSE CAVE
JP4884772B2 (ja) * 2003-08-04 2012-02-29 杏林製薬株式会社 経口徐放性錠剤
US7943585B2 (en) * 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
WO2006007323A2 (en) * 2004-06-28 2006-01-19 Alza Corporation Dosage forms for low solubility and/or low dissolution rate free acid pharmaceutical agents
CA2589551A1 (en) * 2004-12-03 2006-06-08 Dr. Reddy's Laboratories Ltd. Modified release ciprofloxacin compositions
MX2007012642A (es) * 2005-04-11 2008-01-11 Abbott Lab Composiciones farmaceuticas que tienen perfiles mejorados de disolucion para farmacos poco solubles.
DE602006012962D1 (de) * 2006-07-19 2010-04-29 Tabuk Pharmaceutical Mfg Co Pharmazeutische Zubereitungen von Ciprofloxacin
WO2008078730A1 (ja) 2006-12-26 2008-07-03 Translational Research, Ltd. 経鼻投与用製剤
NZ588695A (en) * 2008-03-21 2012-11-30 Mylan Pharmaceuticals Inc Extended release forumulation containing a wax and ciprofloxacin
US8524278B2 (en) * 2009-02-13 2013-09-03 Romark Laboratories L.C. Controlled release pharmaceutical formulations of nitazoxanide
US9101539B2 (en) * 2009-05-15 2015-08-11 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
US11033624B2 (en) * 2010-06-02 2021-06-15 Novaflux Inc. Medical item for prevention and treatment of ear infection
CN102247313A (zh) * 2010-06-11 2011-11-23 北京润德康医药技术有限公司 一种以莫西沙星为活性成分的口服缓释固体制剂
US10285865B2 (en) 2014-05-02 2019-05-14 Novaflux Inc. Drug-releasing device usable in mucosal body cavities
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2951792A (en) 1959-11-18 1960-09-06 Smith Kline French Lab Sustained release pharmaceutical tablets
FR2100858B1 (zh) 1970-07-03 1975-06-06 Daiichi Seiyaku Co
US4122157A (en) 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
US4293539A (en) 1979-09-12 1981-10-06 Eli Lilly And Company Controlled release formulations and method of treatment
FR2470599A1 (fr) 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
DE3142854A1 (de) 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4370313A (en) 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
US4369172A (en) 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4530928A (en) 1982-01-13 1985-07-23 Merck & Co., Inc. Quinoline carboxylic acid complexes with guanidinium carbonate
US4440740A (en) 1982-04-26 1984-04-03 Merck & Co., Inc. α-Keto aldehydes as enhancing agents of gastro-intestinal drug absorption
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
IT1198386B (it) 1982-07-06 1988-12-21 Lepetit Spa Un prodotto a rilascio protratto contenente il suloctidile
IL70071A (en) 1982-11-01 1987-12-31 Merrell Dow Pharma Multilayered sustained release pharmaceutical tablets having non-uniform distribution of active ingredient
US4478822A (en) 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4639458A (en) 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
NL8500724A (nl) 1985-03-13 1986-10-01 Univ Groningen Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.
FR2585246A1 (fr) 1985-07-26 1987-01-30 Cortial Procede d'obtention de formes pharmaceutiques solides a liberation prolongee
US5188840A (en) 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
US4734285A (en) 1985-10-28 1988-03-29 The Dow Chemical Company Sustained release compositions
IT1188212B (it) 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
JPS62195323A (ja) * 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
ATE71293T1 (de) 1986-09-18 1992-01-15 London Pharmacy Innovation Arzneiformulierung.
US4869908A (en) 1987-01-09 1989-09-26 K.V. Pharmaceutical Co. Fibre formulations
US4786503A (en) 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US5200193A (en) 1987-04-22 1993-04-06 Mcneilab, Inc. Pharmaceutical sustained release matrix and process
DE3720757A1 (de) 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
US5472710A (en) * 1988-04-16 1995-12-05 Schwarz Pharma Ag Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture
US5032406A (en) 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
US5007790A (en) 1989-04-11 1991-04-16 Depomed Systems, Inc. Sustained-release oral drug dosage form
US5085865A (en) 1989-04-12 1992-02-04 Warner-Lambert Company Sustained release pharmaceutical preparations containing an analgesic and a decongestant
DK469989D0 (da) 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
IT1237904B (it) 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
JPH0624959A (ja) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk 胃内浮遊型薬物徐放性固形製剤
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
JP2958731B2 (ja) * 1992-02-14 1999-10-06 日本特殊陶業株式会社 酸化アルミニウム基焼結体及びその製造方法
US5582837A (en) 1992-03-25 1996-12-10 Depomed, Inc. Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
IT1255522B (it) 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
IT1256393B (it) 1992-11-17 1995-12-04 Inverni Della Beffa Spa Forme matriciali multistrato per il rilascio controllato di principi attivi
JP2686215B2 (ja) 1993-04-28 1997-12-08 信越化学工業株式会社 徐放性錠剤
IT1264696B1 (it) 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
US5464633A (en) 1994-05-24 1995-11-07 Jagotec Ag Pharmaceutical tablets releasing the active substance after a definite period of time
US5900425A (en) 1995-05-02 1999-05-04 Bayer Aktiengesellschaft Pharmaceutical preparations having controlled release of active compound and processes for their preparation
CN1048628C (zh) 1995-07-06 2000-01-26 东北制药总厂 环丙沙星注射液的制备方法
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
IT1282650B1 (it) 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
US5972389A (en) 1996-09-19 1999-10-26 Depomed, Inc. Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
PT998271E (pt) 1997-06-06 2005-10-31 Depomed Inc Formas de dosagem oral de farmacos com retencao gastrica para a libertacao controlada de farmacos altamente soluveis
IN186245B (zh) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
BR9812553B1 (pt) * 1997-09-25 2010-06-01 formulação medicamentosa em pélete de difusão controlada e em um sistema matriz.
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
NZ510487A (en) 1998-09-14 2003-04-29 Ranbaxy Lab Ltd Pharmaceutical composition comprising ciprofloxacin, sodium alginate, xanthan gum and a cross-linker polymer in a tablet or capsule form
IL149421A0 (en) 1999-11-02 2002-11-10 Depomed Inc Pharmaceutical compositions containing fed mode inducing agents
AU767812B2 (en) 2000-02-04 2003-11-27 Depomed, Inc. Shell-and-core dosage form approaching zero-order drug release
US6488962B1 (en) 2000-06-20 2002-12-03 Depomed, Inc. Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
US6780057B2 (en) * 2001-12-21 2004-08-24 Intel Corporation Coaxial dual pin sockets for high speed I/O applications

Also Published As

Publication number Publication date
DOP2001000199A (es) 2002-05-15
CY1107574T1 (el) 2013-03-13
PL360632A1 (en) 2004-09-20
CZ20024216A3 (cs) 2003-04-16
AR029688A1 (es) 2003-07-10
HN2001000132A (es) 2001-09-11
HRP20030050B1 (en) 2011-07-31
BR0111911A (pt) 2003-05-13
US20070065509A1 (en) 2007-03-22
BRPI0111911B1 (pt) 2015-08-25
CZ301812B6 (cs) 2010-06-30
CA2414271A1 (en) 2002-12-23
ES2282270T3 (es) 2007-10-16
IL153333A (en) 2010-05-31
US20070237824A1 (en) 2007-10-11
SV2002000505A (es) 2002-12-02
WO2002000219A1 (de) 2002-01-03
EE200200707A (et) 2004-08-16
JP4958373B2 (ja) 2012-06-20
SI1296685T1 (sl) 2007-06-30
US8187632B2 (en) 2012-05-29
CN1438889A (zh) 2003-08-27
DE50112123D1 (de) 2007-04-12
ATE355062T1 (de) 2006-03-15
RU2332204C2 (ru) 2008-08-27
DE10031043A1 (de) 2002-02-14
HUP0300953A2 (hu) 2003-08-28
JP2004504278A (ja) 2004-02-12
NO20026160D0 (no) 2002-12-20
PT1296685E (pt) 2007-05-31
HUP0300953A3 (en) 2009-04-28
NO325415B1 (no) 2008-04-21
SK18212002A3 (sk) 2003-04-01
MA25761A1 (fr) 2003-04-01
HU229806B1 (en) 2014-07-28
HRP20030050A2 (en) 2004-06-30
BG65914B1 (bg) 2010-05-31
CA2414271C (en) 2005-09-27
ZA200210350B (en) 2004-02-10
PE20020207A1 (es) 2002-04-27
AU2001270573A1 (en) 2002-01-08
PL203710B1 (pl) 2009-11-30
KR20030023883A (ko) 2003-03-20
US7780986B2 (en) 2010-08-24
SK287384B6 (sk) 2010-08-09
US7709022B2 (en) 2010-05-04
US20040024018A1 (en) 2004-02-05
CN1273138C (zh) 2006-09-06
CU23264B7 (es) 2008-03-14
TWI279232B (en) 2007-04-21
EP1296685B1 (de) 2007-02-28
MY140994A (en) 2010-02-12
UA83616C2 (uk) 2008-08-11
NO20026160L (no) 2002-12-20
MXPA02012727A (es) 2003-05-14
KR100939617B1 (ko) 2010-02-01
EE04992B1 (et) 2008-04-15
NZ523352A (en) 2004-08-27
GT200100126A (es) 2002-01-31
EP1296685A1 (de) 2003-04-02
IL153333A0 (en) 2003-07-06
DK1296685T3 (da) 2007-05-07
BG107372A (bg) 2003-09-30
BRPI0111911B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
IL153333A (en) Sustained-release preparations of quinolone antibiotics and method for preparation thereof
DK0977557T3 (da) Pelletpræparat til behandling af tarmkanalen
GB0011020D0 (en) Intercepting system API calls
AU2002216657A1 (en) One-piece closed-shape structure and method of forming same
AU2001263229A1 (en) Compositions and methods for administration of pharmacologically active compounds
IS1940B (is) Lyfjasamsetningar sem innihalda HMG afoxunarensímlata
MXPA03003168A (es) Composicion antibiotica topica para el tratamiento de infeccion de los ojos.
AU4361400A (en) System for prevention of double counting of events
AU2637801A (en) Methods of forming semiconductor structures
EP1247456A3 (en) Palatable pharmaceutical compositions for companion animals
WO2003020200A8 (en) A novel pharmaceutical compound and methods of making and using same
AP2001002325A0 (en) Novel crystalline forms of a macrolide antibiotic
AU2001269239A1 (en) Use of c4-c10 acids for preventing gram-negative bacterial infections
WO2002038106A3 (en) Calcilytic compounds
AU2002214883A1 (en) Isolation of taxanes
AU2002221319A1 (en) Detection of compounds such as thyroxine
WO2001074787A3 (en) Crystalline pharmaceutical
AU2002334761A1 (en) Methods of treating drug-resistant bacterial infections
AU2001258718A1 (en) An improved process for the preparation of quinolone derivatives
AU2002338241A1 (en) Means for inhibiting proteolytical processing of parkin
AU2000279108A1 (en) Opimization of service access
GB0017822D0 (en) Pharmaceutically active compound
AU2002250276A1 (en) Processing of magnesium-boride superconductors
AU5476901A (en) A method of administering an antitumour compound
AU2000258438A1 (en) An improved process for the preparation of acylferrocenes

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20210612